top of page
Esta página web se diseñó con la plataforma
.com
. Crea tu página web hoy.Comienza ya

Publications

  1. Syu JJ, Chang CH, Chang PY, Liu CH, Yu CJ, Jou TS* . Lipid raft interacting galectin 8 regulates primary ciliogenesis.FASEB J. 2023 Dec;37(12):e23300. doi: 10.1096/fj.202301943R.[PubMed]

  2. Feng HP, Liu YC, Wang CL, Liao WC, Yu JS, Yu CJ*. Acetylation regulates the nucleocytoplasmic distribution and oncogenic function of karyopherin alpha 2 in lung adenocarcinoma.​ Biochem Biophys Res Commun. 2023 Jun 4;659:96-104. doi: 10.1016/j.bbrc.2023.04.014. Epub 2023 Apr 7.[PubMed]

  3. Liu YC, Lin YH, Chi HC, Huang PS, Liao CJ, Liou YS, Lin CC, Yu CJ, Yeh CT, Huang YH, Lin KH*. CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance. Clin Epigenetics. 2022 Aug 23;14(1):106. doi: 10.1186/s13148-022-01326-3.[PubMed]​

  4. Lin MC, Yu CJ,  Lee FJ*. Phosphorylation of Arl4A/D promotes their binding by the HYPK chaperone for their stable recruitment to the plasma membrane. Proc. Natl. Acad. Sci. U S A. 2022 Jul 26;119(30):e2207414119. doi: 10.1073/pnas.2207414119. Epub 2022 Jul 20.[PubMed]​

  5. Wang YH, Chiu WY, Chen YT, Cai PJ, Wu YC, Wu JL, Chen BH, Liu YW, Yu CJ, Lee FJ*. Golgin Imh1 and GARP complex cooperate to restore the impaired SNARE recycling transport induced by ER stress. Cell Rep. 2022 Mar 22;38(12):110488. doi: 10.1016/j.celrep.2022.110488.[PubMed]​

  6. Liao WC, Lin TJ, Liu YC, Wei YS, Chen GY, Feng HP, Chang YF, Chang HT, Wang CL, Chi HC, Wang CI, Lin KH, Ou Yang WT, Yu CJ*. Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma. Cancer Sci. 2022 Jan;113(1):205-220. doi: 10.1111/cas.15197. Epub 2021 Nov 25.[PubMed]​

  7. Feng HP, Cheng HY, TF Hsiao, Lin TW, Hsu JW, Huang LH, Yu CJ*.  ArfGAP1 acts as a GTPase-activating protein for human ADP-ribosylation factor-like 1 protein. FASEB J. 2021 Apr;35(4):e21337. doi: 10.1096/fj.202000818RR. [PubMed]​

  8. Hsiao TF, Wang CL, Wu YC, Feng HP, Chiu YC, Lin HY, Liu KJ, Chang GC, Chien KY, Yu JS, Yu CJ*. Integrative omics analysis reveals soluble cadherin-3 as a survival predictor and an early monitoring marker of EGFR tyrosine kinase inhibitor therapy in lung cancer. Clin Cancer Res. 2020 Jul 1;26(13):3220-3229. doi: 10.1158/1078-0432.CCR-19-3972. Epub 2020 Mar 10.[PubMed]​

  9. Chen KJ, Chiang TC, Yu CJ, Lee FJ*. Arl4A and Pak1 cooperative recruitment to plasma membrane contributes to    sustained Pak1 activation for cell migration. J. Cell Sci. 2020 Feb 4;133(3). pii: jcs233361. doi: 10.1242/jcs.233361.​[PubMed]

  10. Chang JW, Shih CL, Wang CL, Luo JD, Wang CW, Hsieh JJ, Yu CJ, Chiou CC*. Transcriptomic analysis in liquid biopsy identifies circulating PCTAIRE-1 mRNA as a biomarker in NSCLC. Cancer Genom. Proteom. 2020 Jan-Feb;17(1):91-100.[PubMed]

  11. Huang JX, Wu YC, Cheng YY, Wang CL,Yu CJ*. IRF1 Negatively regulates oncogenic KPNA2 expression under growth stimulation and hypoxia in lung cancer cells. Oncotargets Ther. 2019 Dec; 2019(12): 11475-11486.[PubMed]

  12. Ho ML, Kuo WK, Chu LJ, Yeh IH, Fan CW, Chang HI, Yuan CL, Chou TY, Chen HY, Yang SW, Chang LC, Luo M, Wu TH, Chang YI, Yu CJ, Hua CC*, Ng WV*. N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies. Anticancer Res. 2019 Nov;39(11):6317-6324. [PubMed]  

  13. Chen YC, Jiang PH, Chen HM, Chen CH, Wang YT, Chen YJ, Yu CJ, Teng SC*. Glucose intake hampers PKA-regulated HSP90 chaperone activity. Elife. 2018 Dec 5;7. pii: e39925. doi: 10.7554/eLife.39925. [PubMed]

  14. Lin YH, Wu MH, Huang YH, Yeh CT, Chi HC, Tsai CY, Chuang WY, Yu CJ, Chung IH, Chen CY, Lin KH*. Thyroid hormone negatively regulates tumorigenesis through suppression of BC200. Endocr. Relat. Cancer. 2018 Dec 1;25(12):967-979. doi:10.1530/ERC-18-0176. [PubMed]

  15. Hsu RM, Zhong CY, Wang CL, Liao WC, Yang C, Lin SY, Lin JW, Cheng HY, Li PY, Yu CJ*. Golgi tethering factor golgin-97 suppresses breast cancer cell invasiveness by modulating NF-κB activity. Cell Commun Signal. 2018 Apr 27;16(1):19. doi: 10.1186/s12964-018-0230-5. [PubMed]

  16. Wang CI, Yu CJ, Huang Y, Yi JS, Cheng HW, Kao HK, Lao WW, Chang KP*. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer. Head Neck. 2018 Mar 15. doi: 10.1002/hed.25145.  (equal to first author) [PubMed]

  17. Hsieh MH, Chen YT, Chen YT, Lee YH, Lu J, Chien CL, Chen HF, Ho HN, Yu CJ, Wang ZQ, Teng SC*. PARP1 controls KLF4-mediated telomerase expression in stem cells and cancer cells. Nucleic Acids Res. 2017 Oct 13;45(18):10492-10503. doi: 10.1093/nar/gkx683. [PubMed]

  18. Yang CW, Tseng SF, Yu CJ, Chung CY, Chang CY, Pobiega S, Teng SC*. Telomere shortening triggers a feedback loop to enhance end protection.Nucleic Acids Res. 2017 Aug 21;45(14):8314-8328. doi: 10.1093/nar/gkx503. [PubMed]

  19. Yu CJ, Lee FJ*. Multiple activities of Arl1 GTPase in the trans-Golgi network. J. Cell Sci. 2017 May 15;130(10):1691-1699. [PubMed]

  20. Tsai CH, Chen YJ, Yu CJ, Tzeng SR, Wu IC, Kuo WH, Lin MC, Chan NL, Wu KJ, Teng SC*. SMYD3-Mediated H2A.Z.1 Methylation Promotes Cell Cycle and  Cancer Proliferation. Cancer Res. 2016 Oct 15;76(20):6043-6053. [PubMed]

  21. Hsu CH, Hsu CW, Hsueh C, Wang CL, Wu YC, Wu CC, Liu CC, Yu JS, Chang YS, Yu CJ*. Identification and characterization of potential biomarkers by quantitative tissue proteomics of primary lung adenocarcinoma. Mol. Cell. Proteomics 2016 Jul;15(7):2396-410 . [PubMed]

  22. Wang CI, ChenYY, Wang CL, Yu JS, Chang YS, Yu CJ*. mTOR regulates proteasomal degradation and Dp1/E2F1-mediated transcription of KPNA2 in lung cancer cells. Oncotarget 2016 May 3;7(18):25432-42. [PubMed]

  23. Hsu JW, Tang PH, Wang IH, Liu CL, Chen WH, Tsai PC, Chen KY, Chen KJ, Yu CJ, Lee FJ*. Unfolded protein response regulates yeast small GTPase Arl1p activation at late Golgi via phosphorylation of Arf GEF Syt1p. Proc. Natl. Acad. Sci. U S A., 2016 Mar 22;113(12):E1683-90. [PubMed]

  24. Shih CL, Chong KY, Hsu SC, Chien HJ, Ma CT, Chang JW, Yu CJ*, Chiou CC*. Development of a magnetic bead-based method for the collection of circulating extracellular vesicles. N. Biotechnol. 2016 Jan 25;33(1):116-22. [PubMed]

  25. Liu PJ, Chen C, Wang CL, Wu YC, Hsu CW, Lee CW, Huang LH, Yu JS, Chang YS, Wu CC*, Yu CJ*.In-depth proteomic analysis of six types of exudative pleural effusions  for non-small cell lung cancer  biomarkerdiscovery. Mol. Cell. Proteomics 2015 Apr;14(4):917-32. [PubMed]

  26. Wang CI, Wang CL, Wu YC, Feng HP, Liu PJ, Chang YS, Yu JS,Yu CJ*. Quantitative proteomics reveals a novelrole of karyopherin alpha 2 (KPNA2) in cell migration  through the regulation of vimentin-pErkprotein complex levels in lung cancer. J. Proteome Res. 2015 Apr 3;14(4):1739-51. [PubMed]

  27. Lee CW, Chang KP, Chen YY, Liang Y, Hsueh C, Yu JS, Chang YS, Yu CJ*. Overexpressed tryptophanyl-tRNA synthetase, an angiostatic protein, enhances oral cancer cell invasiveness. Orcotarget 2015 Sep 8; 6(26):21979-92. [PubMed]

  28. Huang LH, Lee WC, You ST, Cheng CC, Yu CJ*. Arfaptin-1 negatively regulates Arl1-mediated retrograde transport. PLoS One 2015 Mar 19;10(3): e0118743. [PubMed]

  29. Shih CL, Luo JD, Chang JW, Chen TL, Chien YT, Yu CJ*, Chiou CC*. Circulating messenger rna profiling with microarray and next-generation sequencing: cross-platform comparison. Cancer Genomics Proteomics. 2015 09-10;12(5):223-230. [PubMed]

  30. Yu CJ*, Ko CJ, Hsieh CH, Chien CT, Huang LH, Lee CW, Jiang CC*. Proteomic analysis of osteoarthritic chondrocyte reveals the hyaluronic acid-regulated proteins involved in chondroprotective effect under oxidative stress. J. Proteomics 2014 Mar 17;99:40-53. [PubMed]

  31. Chang SW, Fann CS, Su WH, Wang YC, Weng CC, Yu CJ, Hsu CL, Hsieh AR, Chien RN , Chu CM, Tai DI*. A genome-wide association study on chronic HBV infection and its clinical progression in male  Han-Taiwanese.  PLoS One 2014 Jun 18;9(6):e99724. [PubMed]

  32. Chen CD, Wang CL, Yu CJ, Chien KY, Chen YT, Chen MC, Chang YS, Wu CC, Yu JS. Targeted proteomics pipeline reveals potential biomarkers for the diagnosis of metastatic lung cancer in pleural effusion. J Proteome Res. 2014 Jun 6;13(6):2818-29. [PubMed]

  33. Wang CI, Chien KY, Wang CL, Chang YS, Yu JS, Yu CJ*. Quantitative proteomics reveals regulation of KPNA2and its potential novel cargo protein in non-small cell lung cancer. Mol. Cell. Proteomics 2012 Nov; 11(11):1105-22. [PubMed]

  34. Yu CJ*, Wang CL, Wang CI, Chen CD, Dan YM, Wu CC, Wu YC, Lee IN, Tsai YH, Chang YS, Yu JS. Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology. J. Proteome Res. 2011 Oct 7;10(10):4671-82. [PubMed] 

  35. Yu CJ, Chang KP, Chang YJ, Hsu CW, Liang Y, Yu JS, Chi LM, Chang YS, Wu CC*. Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using Omics-based analysis. J. Proteome Res. 2011 Aug 5;10(8):3778-88. [PubMed]

  36. Wang CI, Wang CL, Wang CW, Chen CD, Wu CC, Tsai YH, Chang YS, Yu JS, Yu CJ*. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome. Int. J. Cancer. 2011 May 15;128(10):2364-72. [PubMed]

  37. Wu CC, Hsu CW, Chen CD, Yu CJ, Chang KP, Dai DI, Liu HP, Su WH, Chang YS, Yu JS*. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol. Cell. Proteomics 2010 Jun;9 (6):1100-17. [PubMed]

  38. Chen KY, Tsai PC, Hsu JW, Hsu HC, Fang CY, Chang LC, Tsai YT, Yu CJ, Lee FJ*. Syt1p promotes activation of Arl1p at the late Golgi to recruit Imh1p. J. Cell Sci. 2010 Sep;14(123): 3478-3489. [PubMed]

  39. Wang CL, Wang CI, Liao PC, Chen CD, Liang Y, Chuang WY, Tsai YH, Chen HC, Chang  YS, Yu JS, Wu CC*, Yu CJ*. Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker  for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural  effusion proteome. J. Proteome Res. 2009 Oct 2;8(10):4428-4440. [PubMed]

  40. Tse KP, Su WH, Chang KP, Tsang NM, Yu CJ, Tang P, See LC, Hsueh C, Yang ML, Hao SP, Li HY, Wang MH, Liao LP, Chen LC, Lin SR, Jorgensen TJ, Chang YS*, Shugart YY.  Genome-wide association study  reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am. J. Hum. Genet.2009 Aug;85(2): 194-203. [PubMed]

  41. Chi LM, Lee CW, Chang KP, Hao SP, Lee HM, Liang Y, Hsueh C, Yu CJ, Lee IN, Chang YJ, Lee SY, Yeh YM, Chang YS, Chien KY*, Yu JS*. Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC- ESI-MALDI tandem MS. Mol. Cell. Proteomics 2009 Jul; 8(7):1453-74. [PubMed]

  42. Lin BR, Yu CJ, Chen WC, Lee HS, Chang HM, Lee YC*, Chien CT*, Chen CF. Green tea extract supplement reduces D-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling. J. Biomed. Sci. 2009 Mar 25; 16(1):35. [PubMed] 

  43. Cheng WL, Wang CS, Huang YH, Liang Y, Lin PY, Hsueh C, Wu YC, Chen WJ, Yu CJ, Lin SR, Lin KH*. Overexpression of a secretory leukocyte protease inhibitor in human  gastric cancer. Int. J. Cancer. 2008 Oct 15;123(8):1787-96. [PubMed]

  44. Wu CC, Chen HC, Chen SJ, Liu HP, Hsieh YY, Yu CJ, Tang R, Hsieh LL, Yu JS*, Chang YS. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 2008 Jan; 8(2): 316-32. [PubMed] 

  45. Yu CJ, Chen YC, Hsiao CH, Kuo TC, Chang SC, Lu CY, Wei WC, Lee CH, Huang LM, Chang MF, Ho HN, Lee FJ*. Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus. FEBS Lett.2004 May 7; 565(1-3):111-6. [PubMed]

  46. Yu CJ, Lin YF, Chiang BL, Chow LP*. Proteomics and immunological analysis of a novel shrimp allergen, Pen m 2. J. Immunol.2003 Jan 1;170(1):445-53. [PubMed] 

  47. Yu CJ, Chen YM, Su SN, Forouhar F, Lee SH, Chow LP*. Molecular and immunological characterization and IgE epitope mapping of Pen n 18, a major allergen of Penicillium notatum. Biochem. J. 2002 May 1;  363(Pt 3):707-15. [PubMed]

  48. Chern CL, Yu CJ, Tsai CH, Liu TZ*. Periodate-catalyzed oxidative coupling of aniline-derived p-aminophenol with p-xylenol as a detection method for hydroxyl radicals. Anal. Lett. 2001 34: 2477-2484. [PubMed]

  49. Chow LP*, Liu SL, Yu CJ, Liao HK, Tsai JJ, Tang TK. Identification and expression of an allergen Asp f 13 from A. fumigatus and epitope mapping using human IgE antibodies and rabbit polyclonal antibodies. Biochem. J. 2000 Mar 1; 346 Pt 2:423-31. [PubMed]

  50. Chow LP*, Chiou SH, Hsiao MC, Yu CJ, Chiang BL. Characterization of Pen n 13, a major allergen from the mold Penicillium notatum. Biochem. Biophys. Res. Commun. 2000 Mar 5;269(1):14-20. [PubMed]

  51. Yu CJJ, Chiou SH, Lai WY, Chiang BL, Chow LP*. Characterization of a novel allergen, a major IgE-binding protein fro Aspergillus flavus, as an alkaline serine protease. Biochem. Biophys. Res. Commun. 1999 Aug 11; 261(3):669-75. [PubMed]

  52. Chow LP*, Su NY, Yu CJ, Chiang BL, Shen HD. Identification and expression of Pen c 2, a novel allergen from the Penicillium citrinum. Biochem. J. 1999 Jul 1; 341 (Pt 1):51-9. [PubMed] 

  53. Su NY, Yu CJ, Shen HD, Pan FM, Chow LP*. Pen c 1, a novel enzymic allergen protein from Penicillium citrinum. Purification, characterization, cloning and expression. Eur. J. Biochem. 1999 Apr; 261(1):115-23. [PubMed]

  54. Kao JT*, Hsiao WH, Yu CJ, Chiang FT. Newly identified missense mutation reduces lipoprotein lipase activity in Taiwanese patients with hypertriglyceridemia. J. Formos. Med.  Assoc. 1999 Sep; 98(9):606-12. [PubMed]

Presentations

  1.  Fang C, Yu CJ* (2017). Asparaginyl-tRNA synthetase plays the role in modulation of lung adenocarcinoma progression. The
      25th Symposium on Recent Advances in Cellular and Molecular Biology, Feb 8-10, Pingtung,Taiwan. 

  2.  Yu CJ*, Cheng YY, Feng HP, Li PY, Wang CL. (2017). Characterizing the transcriptional regulation of importin α1 expression in
      non-small cell lung cancer. Experimental Biology, Apr. 22-26, Chicago, USA. FASEB J April 2017 31:lb172. 

  3.  Hsu CH, Hsu CW, Hsueh C, Wang CL, Wu YC, Wu CC, Liu CC, Yu JS, Chang YS, Yu CJ* (2016). Discovering ERO1L and NARS as the
       potential lung adenocarcinoma diagnosis/prognosis biomarkers by quantitative tissue proteomics analysis. HUPO 15th
       Annual World Congress, Sep 18-21, Taipei, Taiwan. 

  4.  Hsu CH, Wu CC, Hsueh C, Wang CL, Wu YC, Hsu CW, Liu CC, Yu JS, Chang YS, Yu CJ* (2016). Profiling stage-related tissue
       proteomes to discover potential diagnostic and prognostic biomarkers for lung adenocarcinoma. Experimental Biology, Sep
​       18-21, San Diego, USA. .

  5.  Lee CW, Chang KP, Chen YY, Liang Y, Hsueh C, Yu JS, Chang YS, Yu CJ* (2016). The clinical significance and a novel role of
       tryptophanyl-tRNA synthetase, an angiostatic protein, in oral squamous cell carcinoma. The 24th Symposium on Recent
       Advances in Cellular and Molecular Biology, Jan 27-29, Pingtung, Taiwan. 

  6.  Wang CI, Wang CL, Wu YC, Feng HP, Liu PJ, Chen YY, Chang YS, Yu JS, Yu CJ* (2016). Proteomic exploration of invasiveness-
       associated KPNA2 (importin α1) interactome and its upstream signaling in lung cancer. . HUPO 15th Annual World Congress,
       Sep 18-21, Taipei, Taiwan.

  7.  Hsu CH, Liu CC, Liang Y, Yu JS , Chang YS, Wu CC* and Yu CJ * (2015). Discovery of metastasis-related biomarkers in lung
       cancer by quantitative tissue proteomics. 2015 TPS Annual Meeting, Integration of Omics for human health research:
       Genomics, proteomics & Metabolomic, Nov. 13-14, Tao-Yuan, Taiwan. 

  8.  Hsu CH, Liu CC, Liang Y, Yu JS, Chang YS, Wu CC*, and Yu CJ* (2015). Discovery of metastasis-related biomarkers in lung
       cancer by quantitative tissue proteomics. HUPO 14th Annual World Congress, Sep. 27-30, Vancouver, Canada.
 
  9.  Hsu CH, Wu CC and Yu CJ* (2015). Discovering potential lung cancer biomarkers by quantitative tissue proteomics analysis.
       第 14 屆兩岸生物醫學討論會-蛋白質科學的研究, Oct. 26-29, Shanghai Institute of Biochemistry and Cell Biology, Chinese
       Academy of Sciences, Shanghai, China.

 10.  Huang LH, Lee WC, You ST, Cheng CC and Yu CJ* (2015). Arfaptin-1 negatively regulates Arl1-mediated retrograde
       transport. Experimental Biology, Mar. 28-Arp. 1, Boston, USA.

 11.  Wang CI, Wang CL, Wu YC, Feng HP, Liu PJ, Chang YS, Yu JS, Yu CJ* (2015). Quantitative proteomics reveals a novel role of
       karyopherin alpha 2 (KPNA2) in cell migration through the regulation of vimentin-pErk protein complex levels in lung
       cancer. 2015 TPS Annual Meeting, Integration of Omics for human health research: Genomics, proteomics & Metabolomics,
       Nov. 13-14, Tao-Yuan, Taiwan. 

 12.  Huang LH, Lee WC, You ST, Cheng CC and Yu CJ* (2014). Arfaptin-1 negatively regulates Arl1-mediated retrograde transport.
       The 15th IUBMB-24th FAOBMB-TSBMB conference, Oct. 21-26, Taipei, Taiwan.

 13.  Liu PJ, Chen C, Wang CL, Wu YC, Hsu CW, Lee CW, Huang LH, Yu JS, Chang YS, Wu CC*, Yu CJ* (2014). In-depth proteomic
​       analysis of six types of exudative pleural effusions for non-small cell lung cancer biomarker discovery. Oral Presentation
       Award, Nov. 11-12, TPS Translational and Systems Biology Symposium, Taipei,Taiwan. 

 14.  Yu CJ*, Ko CJ, Hsieh CH, Chien CT, Huang LH, Jiang CC. (2014). Proteomic analysis of osteoarthritic chondrocyte reveals the
       hyaluronic acid-regulated proteins involved in chondroprotective effect under oxidative stress. Experimental Biology, 2014
       Apr. 26-30 , San Diego , USA.

 15.  Lee CW, Wang CL, Wang YW, Wang YM, Yu JS, Chang YS, Yu CJ* (2013). Serum protein biomarkers discovery for early
       detection/monitor treatment response of epidermal growth factor receptor tyrosine kinase inhibitor in non-small cell lung
       cancer. HUPO 12th Annual World Congress, 2013 Sep. 14-18 , Yokohama, Japan. 

 16.  Liu PJ, Chen CD, Wang CL, Chang YS, Yu JS, Wu CC*, Yu CJ* (2013). Deep analysis of pleural effusionproteomes  for lung
       cancer biomarker discovery. 2013 Taiwan Proteomics Society International Conference: Recent Advances in Translational
       Medicine, 2013 May 24 -25 , Taipei, Taiwan. 

 17.  Liu PJ, Chen CD, Wang CL, Chang YS, Yu JS, Wu CC, Yu CJ* (2013). Lung cancer biomarkers discovery by differential proteome
       analysis from six types of pleural effusions. HUPO 12th Annual World Congress, 2013 Sep. 14-18, Yokohama, Japan.

 18.  Wang CI, Chien KY, Wang CL, Liu HP, Cheng CC, Chang YS, Yu JS, Yu CJ* (2013). Quantitative proteomics reveals regulation of
​       KPNA2 and its potential novel cargo protein in non-small cell lung cancer. Experimental Biology, 2013 Apr. 20-24 , Boston,
​       USA. 

bottom of page